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1. Introduction  
Most drugs have a widespread distribution in vivo, and effects beyond the disease site need 
to be avoided. As to herbs, it contains many components with different structure and varied 
effects, how to achieve the desired effect at the required site is a great challange. In ancient 
China, people usually get this goal by co-administration of other drugs, and in thousands of 
years, the experience was summarized as meridian guide theory. Since meridian guide 
theory is based on meridian distribution and compatibility, therefore, we should give a brief 
review about meridian, meridian distribution, and meridian guide drug. 
In ancient China, diseases were treated by many methods, such as acupuncture, stone 
needle, drug, medicated bath, application, fumigate, and surgery. Concept of meridian was 
raised with acupuncture. In <Huangdi’s Internal Classics>, the first monograph of China 
published at about 200 BC, diseases were divided according to their meridian, “meridian 
belongs to entrails inside and artus outside”. There are 12 meridians, named as lung 
meridian, large intestine meridian, pericardium meridian, San Jiao meridian, heart 
meridian, small intestine meridian, spleen meridian, stomach meridian, liver meridian, 
gallbladder meridian, kidney meridian and urinary bladder meridian. Name of meridian is 
based on the main entrails the disease correlate and the route it will pass. And in 
<Huangdi’s Internal Classics>, there are descriptions about the position, shape and weight 
of liver, heart, spleen, lung, kidney, intestine, stomach, gallbladder and urinary bladder, 
which are similar to that  of modern anatomy. However, in ancient times, the anatomy was 
rough, and some version is different from modern views. For example, kidney is the main 
organ in kidney meridian, the function of “kidney” in traditional Chinese medicine includes 
kidney and genitical gland located near kidney. At that time, disease diagnosis and 
treatment especially in acupuncture was based on their meridian, such as taiyang diseases, 
yangming diseases, etc. 
In Han dynasty, the famous physician Zhang Zhong-Jing described a method of diagnose -
analyse and differentiate febrile diseases in accordance with the theory of six pairs of 
channels in his book < Treatise on Febrile Diseases> (Fu, 1990). Thereafter, drug use was 
summarized according to syndrome- differentiation of the six meridians. For example, 
nutgrass galingale rhizome is used to treat liver diseases, therefore, its meridian belongs to 
liver; fritillariae tuber is used to treat lung diseases such as cough, asthma, therefore, its 
meridian belongs to Lung; borneol is used to treat heart diseases, its meridian distribution is 
heart, etc. Some drugs have a wide use, its meridian distribution may be two or three 
entrails. For example, bupleuriradix is used to treat diseases of liver, Sanjiao, arcula cordis, 
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and it belonges to these three meridians. And this is the basis for the formation of meridian 
distribution theory. In Tang and Song dynasty, there were some descriptions about drug 
orient and site-direct effect in books <Shi Liao Ben Cao>, <Supplement to the Herbal>, 
<Amplification on Canon of Materia Medica> and <Su Shen Liang Fang>. Thereafter, in Jin 
and Yuan dynasty, the famous physician Zhang Jie-Gu summarized these results and 
combined with his own experiment, raised the concept of meridian distribution. In his book 
<Zhen Zhu Lang>, and <Yi Xue Qi Yuan>, he summarized the experience of drug use 
according to meridian channels, such as “drug used to remove fire in ZANG FU-organ”, 
“Meridian Guide drug of channels”, and described meridian distribution as an important 
item of drug property. He thought that drug effect is related to its channal, and when used 
properly, the effect would be great. For example, Coptis chinensis, schtellaria, paeoniae 
radix, anemarrhenae, caulis hocquartiae, phellodendricortex, and gypsum all had the effect 
of purging pathogenic fire, however, Coptis chinensis is mainly used to purge the sthenic 
heart-fire, scutellaria is mainly used to purte the White, paeoniaeradix is mainly used to 
purge the sthenic liver-fire, caulis hocquartiae is used to rush down the fire in small 
intestine, phellodendricortex is mainly used to purge the fire in bladder. His disciple, 
famous physician Li Dong-Yuan and Wang Hao-Gu inherited his theory and developed it. 
In the book <Yong Yao Fa Xiang> of Li Dong-Yuan and <Materia Medica of Decoction> of 
Wang Hao-Gu, meridian distribution theory was used and improved. In <Materia Medica of 
Decoction>, there were 242 different kinds of drugs, among them, 80 were described as 
drugs with meridian distribution. In this book, drugs with meridian distribution were 
summarized in a table, named as “Guide profiles of various meridians”. Due to its 
effectiveness in choosing drugs to formulate prescription, as it appeared, it was accepted by 
many physicians and more and more experience about drug meridian distribution was 
summarized. Then, in Ming dynasty, two famous physicians Liu Wen-Tai and Jia Ru-Li 
described meridian distribution as an indispensable content of drug property in their book 
<Ben Cao Pin Hui Jing Yao> and <Yao Pin Hua Yi> respectively. Li Shi-Zhen, a famous 
physician and pharmacist in Ming dynasty, inherited and developed the theory of meridian 
distribution of Zhang Jie-Gu in his world-famous book <Compendium of Materia Medica>, 
and indicated that “Chinese lovage is TaiYang meridian drug”, “gypsum is cold Yangming 
meridian drug” etc. The meridian distribution of herbs was introduced when discussing 
drug property, such as “ephedra herb is the herb for lung meridian specially, when treating 
lung diseases, it is usually used.” “frenugreek, herbs of right kidney, when kidney-YANG is 
deficient, it is used when cold-QI incubate in body and could not return to Yuan”, 
“gastrodiarhizome is Qifen herbs belonging to liver meridian, in <Huangdi’s Internal 
Classics>, it was indicated that all kinds of dazzling belongs to liver meridian, therefore, 
gastrodiarhizome could treat dizzy.” Afterwards, meridian distribution was extensively 
described in books <Ben Cao Jing Shu> of Liao Xi-Yong, <Lei Gong Pao Zhi Yao Xing Jie> 
and <Ben Cao Tu Jie> by Li Zhong-Zi, , and more and more people accepted meridian 
distribution theory. 
Meridian guide theory is the combination of meridian distribution and compatibility. It is 
first proposed in Qin and Han dynasty, and was developed in Tang and Song dynasty, 
formed at Jin and Yuan dynasty, completed in Ming and Qing dynasty. At 200 BC, in the 
first herb book <Shennong’s herbal>, there was description that “Jun Gui is the message  of 
other drugs”. In Wei and Jin dynasty, famous physician Tao Hong-Jing described in his 
book <Ming Yi Bie Lu> that “cinnamomicortex guides other drugs”. In Bei Song dynasty, 
Kou Zong-Shuang described in his book <Amplification on Canon of Materia Medica> that 
“Zhang Zhong-Jing used Alismae rhizoma in “Ba Wei Wan”, just used it to guide 
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cinnamomicortex and aconite root into kidney meridian, and no other means”. In Jin and 
Yuan dynasty, Zhang Jie-Gu raised the concept of meridian guide drug. In his book <Zhen 
Zhu Lang>, he called drugs which could enforce other drugs effect at the meridian of its 
own as meridian guide drug, and listed meridian guide drug for twelve meridians. His 
disciple Li Dong-Yuan developed this idea and the theory. And then, in the book 
<Compendium of Materia Medica>, Li Shi-Zhen summarized the work of previous 
physicians, combined his and his father’s experience in treating diseases, and revised the 
meridian guide drug of twelve channels. Also in this book, it is said that 
“ramuluscinnamomi guides other drugs to arm”, “achyranthisradix guides other drugs to 
the lower part of the body” etc. Afterwards, many physicians exercised this method for 
diseases treatment, and got good results.  
The twelve meridian guide drugs are: platycodonradix, angelica root, cimicifugae for lung 
meridian, gypsum and angelica root for large intestine meridian, cortex moutan and 
bupleuriradix for pericardium meridian, forsythia suspensa and bupleuriradix for San Jiao 
meridian, coptis chinensis, asariradix and borneol for heart meridian, Chinese lovage and 
phellodendri for small intestine meridian, atractylodes and cimicifugae for spleen meridian, 
angelica root, gypsum and pueraria for stomach meridian, vinger-baked bupleuriradix, 
evodiaefructus, and green tangerine peel for liver meridian, green tangerine peel and 
bupleuriradix for bladder meridian, cassia and anemarrhenae for kidney meridian, and 
incised notopterygium rhizome for urinary bladder meridian. There are some crossovers in 
meridian guide drug among different channels, for example, bupleuriradix and cimicifugae 
are meridian guide drugs for four channels, angelica root is the meridian guide drug for 
three channels. Besides twelve meridian guide drugs, there are some drugs for site 
targeting, such as chuanxiong for headache; ramulus cinnamomi and mulberry twig for 
Brachialgia; achyranthisradix for melosalgia; notopterygiirhizoma for cervical part disease 
etc. Many physicians practised meridian guide method in treating diseases and had a good 
effect, and they recorded their thoughts in their books. You Zai-Jing, a famous physician, 
said in his book <Yi Xue Du Shu Ji> that “soldiers could not reach enemies’ place if there is 
not a guide, and drugs could not reach the disease site if there is not a meridian guide 
drug”. Another physician in Qing dynasty, Shen Shi-Pao said that “ meridian guide drug 
could induce other drugs to the disease site, and a great effect could be achieved with less 
drug used”. Many famous prescriptions contained meridian guide drug, such as 
bupleuriradix in “Xiao Chai Hu Tang”, gypsum in “Bai Hu Tang”, kudzuvine root in “Ge 
Gen Qin Lian Tang”, platycodiradix in “Sen Ling Bai Zhu San”, and evodiaefructus in “Zuo 
Jin Wan”, achyranthisradix in “San Miao San” and “Hu Qian Wan”. Even in modern times, 
many famous physicians indicated that using meridian guide drug is an effective way for 
drug targeting (R.Z. Zhao et al, 2005).  
Nowdays, more and more drugs are found to have side effects, and these effects affected 
clinical results especially for cancer treatment, about 30% patients give up treatment due to 
serious side effects of anticancer drugs. Many technologies are used to increase the 
therapeutic effect and reduce the side effect. However, site-directed pharmaco-delivery is a 
desirable but elusive goal. Although there are great achievements in target delivery, the 
clinical results were beyond people’s expectation due to the difference between animals and 
human beings. The concept of meridian guide drug is similar to that of target delivery 
system, may be a new way for targeting delivery. Therefore, some studies had been carried 
out to demonstrate the meridian guide theory by experiment.  
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2. Modern study of meridian guide drug 
At present, two methods are usually used to study meridian guide theory. One is 
pharmacokinetics method. This method demonstrated the effect of meridian guide drug by 
comparing drug distribution before and after co-administration with meridian guide drugs. 
This method is based on the hypothesis that drug effect is dependent on its concentration. 
The second method is pharmacological method. Meridian guide effect was investigated by 
comparing the target site effect between drug and their co-administration with meridian 
guide drugs. This method is based on the clinical definition of meridian guide drug. 
Vinegar-baked bupleuriradix, meridian guide drug of liver, platycodiradix, meridian guide 
drug of lung, borneol, meridian guide of heart meridian, and achyranthisradix, meridian 
guide drug of legs have been studied.  
2.1 Study of liver meridian guide drug: vinegar-baked bupleuriradix 
Bupleuriradix, is the dry radix of Bupleurum Chinense DC, and B. Scozoneri folium wide. It 
tastes acrid, and belongs to liver, cholecyst, Sanjiao and pericardium meridian. It is usually 
used in the treatment of influenza, fever, malaria, hepatitis, jaundice, nephritis, dizziness, 
bitter taste in the mouth, lung disease, cancer, and menstrual disorders in China, Japan, and 
other Asia. Pharmacological study showed that it had the effect of anti-inflammatory 
(S.M.Chen et al, 2008), antiviral activities (Chiang, 2003), antioxidant and hepatoprotective 
effect (B.J. Wang et al, 2004) etc. It is the meridian guide drug of liver, pericardium, gall 
bladder and Sanjiao meridian. In traditional Chinese medicine theory, it is regarded that 
drugs with sour taste enters liver first, and when baked with vinegar, it is the liver meridian 
guide only. It is described in the book <Ben Cao Zheng Yi> that “…besides, there is 
stagnation in collaterals and subcollaterals of liver, add few of bupleuriradix, the effect is 
quick”. 
Li Xiao-Dong and Nie Sa et al studied the effect of vinegar on pharmacological and chemical 
of bupleuriradix. The results showed that both pharmacological effect and components in 
the drug changed a little bit due to the vinegar-baked procedure (X.D. Li, 2000; S.Nie et al; 
2008). It was demonstrated that vinegar-baked bupleuriradix had a much stronger effect on 
acesodyne and bile secretion than that of the bupleuriradix (J.Wu, 2008; S.Q Nie et al; 2002). 
Therefore, vinegar-baked bupleuriradix was extensively used in the liver diseases treatment 
medicines (Kou et al, 2006), such as DA Chai Hu Tang, Xiao Yao San, Xiao Chai Hu Tang 
etc. The study method was pharmacokinetics based. 
2.1.1 Vinegar-baked bupleuriradix affected drug distribution 
Four components were chosen in studying the liver targeting effect of vinegar-baked 
bupleuriradix, these are resveratrol (R.Z. Zhao et al., 2009), rhein (R.Z. Zhao et al., 2010), 
oxymatrine (unpublished data), and gentiopicroside (unpublished data). Their structure 
belongs to chrysophenine glycoside, anthraquinone, alkaloid and iridoid glycode 
respectively. In these studies, except resveratrol, animals were divided into two large 
groups according to dose of the components, and in each large group, animals were divided 
into four groups based on the dose of vinegar-baked bupleuriradix. For resveastrol, there 
was only one large group, and subgroup was similar to that of the other studies.  
The detail of the experiment is listed in Table 1. For oral administration, components were 
suspended in solutions containing 1% sodium carboxymethylcellulose or in vinegar-baked 
bupleuriradix solutions containing 1% sodium carboxymethylcellulose. At predetermined 
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time points, six animals were taken out from each group and blood was collected via heart 
puncture. Tissues of interest (heart, liver, spleen, lung, and kidney) were collected 
immediately after cervical dislocation and were blotted dry with tissue paper. Plasma and 
tissue samples were frozen at -80°C until analysis. 
 
Component Animal Detection 
method   
Detected 
components 
subgroups Drug 
dose 
(mg/kg)
Dose of 
vinegar-baked 
bupleuriradix 
(mg/kg) 
resveratrol mice HPLC resveratrol 4 200 300, 600,1200 
rhein rats HPLC Rhein and 
conjugated 
rhein 
8 80, 40 300, 600, 1200 
oxymatrine mice HPLC-MS Oxymatrine and 
matrine 
8 80, 10  400, 800, 1200 
gentiopicroside mice HPLC-MS gentiopicroside 8 100, 50 400, 800,1200 
Table 1. Experiment design of liver targeting effect of vinegar-baked bupleuriradix  
In all the studied animal groups, vinegar-baked bupleuriradix showed liver targeting effects 
for all the components with different degree. This effect is dependent on the dose of vinegar-
baked bupleuriradix, components and its structure. Table 2 listed the most effective group 
within the study. 
Vinegar- baked bupleuriradix enhanced other drugs liver distribution by three ways. First, it 
increased the Cmax of other drugs in liver, this indicated that vinegar-baked bupleuriradix 
enhanced liver uptake of other drug. This effect is component structure related. Among 
these four components, rhein is the most sensitive drug to the effect of vinegar-baked 
bupleuriradix, the maximal increased Cmax ratio in liver was 565%; second sensitive 
component is oxymatrine, the maximal increased Cmax ratio in liver was 89%, the third is 
gentiopicroside, the maximal increased Cmax ratio was 21%; and resveratrol is the least 
sensitive to the effect of vinegar baked bupleuriradix, its Cmax had marginal change. AUC 
is a parameter determined by Cmax and elimination rate. When using AUC as the 
evaluation criteria, rhein is still the most sensitive component to the effect of vinegar-baked 
bupleuriradix, second is oxymatrine. However the third is resveratrol, the increased AUC in 
liver was 79%, and gentiopicroside was the most insensitive component to the effect of 
vinegar-baked bupleuriradix. It should be indicated that although vinegar-baked 
bupleuriradix had marginal effect on the uptake of resveratrol, it decreased the elimination 
rate of resveratrol in liver significantly, also induced an increase in AUC. 
Second, vinegar-baked bupleuriradix decreased AUC and Cmax of these components in 
other tissues. Rhein is the most sensitive components to the effect of vinegar-baked 
bupleuriradix. Low dose of vinegar-baked bupleuriradix decreased the distribution of rhein 
in other tissues except liver, and the decreased AUC ratio was 82%, 57%, 30%, 25% and 15% 
for spleen, heart, blood, lung and kidney respectively. The second sensitive component was 
resveratrol, high dose of vinegar-baked bupleuriradix decreased the distribution of 
resveratrol in kidney, spleen, heart and lung significantly, the decreased AUC ratio was 
30%, 30%, 32% and 30% respectively. The third sensitive component was oxymatrine, 
medium dose of vinegar-baked bupleuriradix decreased the distribution of oxymatrine in 
blood, spleen, heart, and lung, the decreased AUC ratio was 33%, 27%, 17% and 19%, the 
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least sensitive components was gentiopicroside, medium dose of vinegar-baked 
bupleuriradix only decreased the AUC of gentiopicroside in blood and lung, the decreased 
ratio was 17% and 18% respectively.  
 
Drugs AUC 
Changed 
extent in 
liver  
Cmax 
Changed 
extent in  
liver 
AUC Changed extent in 
other tissues 
Cmax Changed 
extent in other 
tissues 
Drug 
distribution 
original 
resveratrol 79% No 
significance
-44% in lung, 58% in 
heart, and 42% in kidney
-46% in kidney, -
23% in lung, and -
16% in heart 
Kidney> liver> 
lung> blood> 
heart> spleen 
rhein 264% 226% -72%, -57%, -30%, -25%, -
15% in spleen, heart, 
blood, lung and kidney 
respectively  
- 31% in heart, and 
-65% in spleen 
Kidney> lung> 
blood> liver> 
spleen> heart 
Conjugated 
rhein 
21% No 
significance
-53%, -48%, -43%, -39% 
and -30% in lung, heart, 
spleen, kidney, and 
blood respectively 
-36% in heart, and 
-23% in kidney 
Spleen> lung> 
kidney> heart > 
liver≈blood 
oxymatrine 152% 89% -33%, -17%, -27%, -19% 
in blood, heart, spleen 
and lung respectively 
56% in kidney, -
36% in lung, -15% 
in blood 
Blood> lung> 
spleen> kidney> 
liver≈ blood 
matrine 32% 20% -73%,-37%, -35%,  -16% 
in lung, blood, heart, and 
kidney respectively 
-63%,-46%,-41%, 
35%,-28% in heart, 
kidney, blood, 
spleen, and lung 
respectively
Blood> liver> 
kidney> spleen≈ 
heart≈ lung 
Gentio-
picroside 
No 
significance 
20% -39%, -27%, -27%, -18% 
in kidney, heart, spleen, 
lung respectively 
-35% ,-36% -15% in 
heart, spleen and 
kidney 
respectively
Kidney> blood> 
liver> lung> 
heart> spleen 
Table 2. The results of vinegar-baked bupleuriradix on the AUC, Cmax of other 
components, listed results were the most effective groups when using relative targeting 
ratio as evaluation index. 
Third, vinegar-baked bupleuriradix decreased the elimination rate of all these four 
components in liver, but increased their elimination rate in other tissues. This may be 
another reason for AUC increase in liver and AUC decrease in other tissues. 
The liver targeting effect of vinegar-baked bupleuriradix also depended on drug and 
vinegar-baked bupleuriradix dose. For resveratrol and gentiopicroside, medium dose of 
vinegar-baked bupleuriradix had the strongest effect. For rhein, in high rhein dose group, 
low dose of vinegar-baked bupleuriradix had the strongest effect, but in low rhein dose 
group, high dose of vinegar-baked bupleuriradix had the strongest effect. For oxymatrine, in 
high oxymatrine dose group, high and medium dose of vinegar-baked bupleuriradix had 
the strongest effect. For gentiopicroside, rhein and oxymatrine, all components were 
sensitive to the effect of vinegar-baked bupleuriradix at their high dose than that at low 
dose. 
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In the study of rhein and oxymatrine, effects of vinegar-baked bupleuriradix on the 
distribution of their metabolites were also studied. Interestingly, similar phenomenon was 
observed when the index is conjugated rhein and matrine. Vinegar-baked bupleuriradix 
increased not only their distribution in liver, but also decreased their distribution in other 
tissues, also showing a liver targeting effect. Compared the sensitivity of rhein, oxymatrine 
together with their metabolites to the effect of vinegar-baked bupleuriradix, rhein 
metabolite was less sensitive than its native form, and rhein dose had marginal effect. 
However, the sensitivity of oxymatrine to the effect of vinegar-baked bupleuriradix was 
dependent on its dose, in high dose group of oxymatrine, oxymatrine was more sensitive 
than its metabolite, anyhow, in low dose group of oxymatrine, matrine was more sensitive 
than its native form.  
When comparing their own distribution and the effect of vinegar-baked bupleuriradix, it is 
found that for the components which are sensitive to the effect of vinegar-baked 
bupleuriradix, their main distribution is not in liver. For rhein and oxymatrine, liver 
distribution was only 5% and 3.8% of the total drug in vivo respectively. However, the two 
components were less sensitive to the effect of vinegar-baked bupleuriradix, their 
distribution in liver was relatively high, AUC in liver was 17% and 17.9% for 
gentiopicroside and resveratrol respectively.  
2.1.2 Liver targeting effect mechanism of Vinegar-baked bupleuriradix  
Effect of vinegar-baked bupleuriradix on drug distribution implied that vinegar-baked 
bupleuriradix may affect cell uptake of the drug and this is related with membrane 
constituents. Therefore, the effect of vinegar-baked bupleuriradix on membrane 
permeability, membrane constituents, pHi and morphology of BRL cell line were 
investigated (unpublished data). In these studies, samples were divided into four groups 
according to the concentration of vinegar-baked bupleuriradix, 10 mg/mL, 2 mg/mL, 0.4 
mg/mL and drug free group, respectively. In each group, samples were further divided into 
3 h, 6 h, 10 h, 18 h, 24 h, 48 h and 72 h subgroups according to the culture time for 
permeability study (n=5), and 3, 6, 12, 24, 48 h for membrane constituents study (n=5), and 
12 h sample for morphology study. Each experiment was repeated five times. Membrane 
permeability was determined by flow cytometry, membrane morphology of BRL was 
observed by electronic microscope, and constituents were determined by automatic 
biochemistry analysator and thin layer chromatography scanning method. 
Vinegar-baked bupleuriradix increased the BRL membrane permeability significantly, and 
this effect was vinegar-baked bupleuriradix concentration dependent, at all the time points, 
high concentration vinegar-baked bupleuriradix had a stronger effect than that of low 
concentration, and as the culture time prolonged, the effect of vinegar-baked bupleuriradix 
concentration on the permeability was more obvious. Further study showed that the 
membrane permeability increase was not due to membrane breakage, but prompting the 
growth of BRL cell. Morphology study showed that compared with the control group, the 
cell surface was much smoother after co-cultured with medium and high dose of vinegar-
baked bupleuriradix, the effect was drug dose dependent. In order to study the reason, the 
content of cholesterol, protein and lipids were determined. Vinegar-baked bupleuriradix 
had marginal effect on the content of cholesterol, and the effect of vinegar-baked 
bupleuriradix on the lipids and protein content was dependent on the culture time and drug 
dose.  
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Cholesterol/phospholipids reflected cell integrity and permeability, when it decreased, the 
increase of permeability is toxic to cells, in this study, however, compared to the control 
group, high and medium dose of vinegar-baked bupleuriradix increased the ratio at 3, 12, 24 
h, only decreased the ratio at 6 h, low dose of vinegar-baked bupleuriradix had marginal 
effect on the ratio.  
Proportion among lipids is related with membrane fluidity, and it is related with membrane 
permeability, especially phosphatidylcholine/phosphatidyl ethanolamine ratio. Like 
cholesterol/phospholipids ratio, when it is decreased, cells are under danger. However, 
vinegar-baked bupleuriradix increased the ratio before 12 h, and thereafter, it had marginal 
effect on it. Membrane constituents were related with transporters, and the effect of vinegar-
baked bupleuriradix on the activity of P- glycoprotein in BRL cell line was also studied, and 
the results showed that vinegar-baked bupleuriradix inhibited the activity of P- 
glycoprotein, this is in accordance with the results of morphological and membrane 
constituents results, and indicated that liver targeting effect of vinegar-baked bupleuriradix 
may be related with transporters.  
2.2 Study of lung meridian guide drug: platycodiradix  
Platycodiradix is the root of Platycodon grandiflorum A. DC, and it is widely used in treating 
diseases of lung and respiratory system, such as laryngopharyngitis, bronchitis, asthma, 
pulmonary tuberculosis, and pneumonia in clinics in China. Pharmacological research 
showed that it is responsible for diverse effects including anti-inflammation, anti-allergy, 
anti-tumor, augmentation of immune response, anti-obesity, anti-oxidation, hypoglycemic 
activity etc (Y.Tai et al, 2009). It is described in book <Ben Cao Qiu Zhen> that 
platycodiradix could promote the function of lung, and guide other drugs to lung. 
Therefore, it is the meridian guide drug of lung.  
The lung target enhancing effect of platycodiradix was studied by pharmacokinetics 
method. Animals were divided into two groups, drug alone group and drugs co-
administration with platycodiradix. Drug concentration and the target evaluation were 
listed in Table 3. The studied components included levofloxadin (Y.L, Li et al., 2006), 
florenicol (Y.L. Li et al., 2008), and roxithromycin (Y.L. Li et al., 2005). 
 
component animal Detection method  Detected 
components 
Drug dose Target 
evaluation 
levofloxacin chicken HPLC levofloxacin 10mg/kg Cmax, AUC 
Florfenicol rabbit HPLC florfenicol 30mg/kg Cmax, AUC 
roxithromycin chicken Biological effect 
method 
roxithromycin 8,10,12mg/kg Cmax, AUC 
Table 3. Experiment design of lung targeting effect of platycodiradix 
Platycodiradix increased the distribution of levofloxacin, florfenicol in lung significantly and 
this effect is platycodiradix dose dependent and components property related. The most 
sensitive component was levofloxacin. When co-administered with platycodiradix, Cmax of 
levofloxacin in lung increased 4.4 times; and its AUC increased 470%, although 
platycodiradix also increased the AUC of levofloxacin in heart and kidney, the increased 
extent was far less than that in lung. Florfenicol was less sensitive than levofloxacin. 
Platycodiradix increased Cmax and AUC of florfenicol in lung. However, it also increased 
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the distribution of florfenicol in liver. Meanwhile it decreased Cmax of florfenicol in blood 
and kidney with the decreased extent of 28% and 44% respectively. 
 
Drugs AUC 
Changed 
extent in 
lung  
Cmax 
Changed 
extent 
inlung 
AUC Changed 
extent in other 
tissues 
Cmax Changed 
extent in other 
tissues 
Drug 
distribution 
original 
Distribution 
ratio of drug 
in lung 
levofloxacin 440% 470% -15% in liver, 50% 
in kidney, 44% in 
heart 
-14% in liver, 
72.7% in heart, 
103% in kidney
Kidney>=liver
>heart=lung 
8.5% 
Florfenicol 50% 59.7% -26% in blood, 
76.8% in liver  
-28% in blood, -
44% in kidney 
110% in liver,  
Kidney> 
lung≈ liver> 
heart 
10.4% 
Roxithro-
mycin 
No 
significance 
36% _ _ _ _ 
Table 4. Results of lung targeting effect of Platycodiradix, _ represent no data 
Effect of platycodiradix on the distribution of roxithromycin was a little different from that 
of others. Although at 10mg/kg dose, platycodiradix increased Cmax of roxithromycin, it 
had marginal effect on AUC, platycodiradix enhanced drug absorption, Tmax of 
roxithromycin was 3 or 4 h for medium and low dose respectively, when co-administered 
with platycodiradix, Tmax was 0.75 h and 1.5 h respectively. In control group, drug was 
absorbed slowly, and there were 3 peaks, but in experimental group, there was only 1 peak. 
Multi-peak usually indicated liver-intestine cycle, and platycodiradix may be able to inhibit 
this cycle and induce a rapid elimination. Since effect of platycodiradix on drug distribution 
in other tissues was not studied, effect of platycodiradix on roxithromycin is not complete. 
This limited our knowledge. 
2.3 Effect of borneol on brain targeting 
Borneol, a simple bicyclic monoterpene with acrid-bitter flavor, belongs to heart, spleen and 
lung meridian, it has the effect of communicating holes and scattering stagnant fire, 
detumescencing and relieving the pain. It is frequently used in the treatment of 
encephalopathy, such as stroke, epilepsy and headache. Pharmacological study showed that 
borneol had the effect of anti-excitation of central nerve induced by picrotoxin, prolong the 
delitescence of hyperspasmia, prolong the survival time of mice under oxygen deficiency, 
and prolong the awareness of tired rats (S.R.Wu & G.Cheng et al, 2001). 
In the book “Amplification on Canon of Materia Medical”, it is said that “borneol is weak 
when used alone, it strengthens the therapeutic action of other herbs when it is used as an 
adjuvant and message drug”, it also had the effect of “commanding other drugs”. In <Plain 
Questions of Huangdi’s Internal Classic>, it is said that “Heart, King of organs, mind 
efferens”, “heart controls mental and emotional activities”, that is to say, brain function in 
ancient China was listed as “Heart”. Therefore it is the meridian guide drug of brain. 
2.3.1 Borneol increased drug concentration in brain 
Brain targeting effect of borneol was studied by determining drug concentration in brain 
and pharmacological method. Drugs studied using the first method included sodium 
ferulate (Z.Z. Lin et al, 2008), carbamazepine (H.Y. Zhou et al, 2008), tetramethylpyra (Y. 
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Wang et al, 2006), methotrexat (Gao et al, 2009), rifampici (S.R. Wu et al, 2004), Panax 
pseudo-ginsing (S.X. Wang et al, 2009), puerarin (C.Y. Gao et al, 2010), gastrodin (Cai et al, 
2008), cidomycin (Q.D. Liu et al, 1994), danshensu (J. Liu et al, 2008) et al. The study design 
was listed in Table 5. 
 
Drugs Animal
Detection 
method  
Detected 
components 
Drug 
dose 
g/kg 
Meridian 
guide drug 
dose (g/kg)
Target evaluation 
Sodium ferulate mice HPLC-MS Sodium ferulate 0.2 0.05,0.002 
Concentration in brain 
and blood 
Carbamazepine mice HPLC 
Carbamazepine, 
10,11- epoxide 
carbamazepine 
 0.75 Cmax, AUC 
Tetramethyl-
pyrazine 
rat HPLC 
Tetramethyl-
pyrazine 
0.0034 0.034 
Concentration in blood 
and brain 
methotrexat Rabbit HPLC Methotrexat 0.1 0.75 Concentration in brain 
Cidomycin rat 
Enzyme 
immu-
nization 
cidomycin 0.035 1.0 Concentration in brain 
rifampici Mice HPLC rifampici 0.182 0.6 AUC 
notoginsenoside 
R1 
rabbit HPLC notoginseng R1 15.0 0.085 
Concentration in 
tissues 
Ginsenoside 
Rg1 
rabbit HPLC ginsenoside Rgl 15.0 0.085 Concentrationin tisues 
Ginsenoside  
Re  
rabbit HPLC ginsenoside Re 15.0 0.085 
Concentration in 
tissues 
Puerarin Rats HPLC puerarin 0.0625 0.3 AUC in brain 
gastrodin mice HPLC gastrodin 0.2 0.4, 0.6 
AUC in brain and 
blood 
danshensu rabbit HPLC-MS Danshnsu 10 0.18 
Concentration in 
tissues 
Table 5. Experiment design of brain targeting effect of borneol  
Among these drugs, cidomycin is aminoglycoside antibiotic, puerarin is a kind of flavonoid, 
notoginsenoside R1, ginsenoside Rg1 and Re are saponin, rifampici is rifomycins antibiotics, 
methotrexat is antifolate drug. Borneol increased their distribution in brain, and this effect is 
borneol dose dependnt and chemical structure related. In the study of borneol to the 
distribution of gastrodin, 40 and 60 mg/kg borneol increased the distribution of gastrodin in 
brain significantly. However, 20 mg/kg had marginal effect on the distribution of gastrodin. 
Among the reported study, Ginsenoside Rg1 was the most sensitive compound to the effect 
of borneol, and drug concentration increase in brain was 2438%. Although it also increased 
drug concentration in other tissues, the increased ratio was far less than that in brain. The 
second sensitive component was notoginsenoside R1, the increased ratio of drug 
concentration in brain was 523%, and borneol also increased drug concentration in other 
tissues in the meantime. The originally distribution of these two components in brain was 
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very low. Borneol also had the effect of decreasing drug concentration in non-target tissues. 
For example, borneol decreased the concentration of tetramethylpyrazine in blood, and 
decreased the concentration of rifampici in liver and kidney.  
 
Drugs % Change
of AUC  in
Brain  
% Change
of Con-
centration 
in brain
AUC Change in 
other tissues 
Cmax Change in 
other tissues 
Drug distribution 
original 
Sodium ferulate 66%  47%  No significance 46% in blood _
Carbamazepine 24.5%  129%   -9%~- 37% in 
lung, liver, 
heart and 
kidney  
 
14%~29%, in liver, 
lung, blood, heart, 
muscle, 175% in 
spleen  
Lung> brain> fat> 
liver> blood> 
kidney> spleen 
>heart > muscle  
epoxide 
carbamazepine 
174.5% 56% -52~- 40% in 
lung, liver and 
heart 
146% in spleen, -
38%, -20.5%,-53% in 
lung, liver and 
heart respectively 
Lung>heart> liver> 
kidney> blood> 
brain> fat> spleen> 
muscle 
Tetramethylpyr
azine 
30% 26 % -15% in blood -10% _ 
methotrexat 75% 56.5% No significance No significance _ 
Cidomycin - 142% - 22.8 _
rifampici 99% 79% -12%, -17%, 
64%, 46% in 
liver, kidney 
lung and blood 
respectively  
-40%,-24% 75% in 
liver , kidney and 
lung respectively 
Liver> kidney> 
lung> blood> brain 
notoginsenoside 
R1 
-- 523% -- 497%，227%，36%
20% in liver, lung, 
heart, kidney 
Heart> kidney> 
lung> liver> brain 
ginsenoside Rgl _ 2438% _ 927%, 567% and 
491% in heart, 
kidney, liver 
lung> liver >kidney 
>heart >brain 
ginsenoside Re _ 71% _ 264%, 251%, 85% 
73% in, liver, lung, 
heart, kidney 
Kidney >heart > 
brain= liver > lung 
Puerarin 191% - - - Lung>>kidney> 
pancreas> liver> 
heart> spleen> brain 
gastrodin 109% 80% No significance No significance
Danshensu _ 355%  -100%, 158%,
104%in heart, liver, 
kidney respectively
Kidney> heart> 
brain >liver 
Table 6. Effect of borneol on drug distribution of other drugs 
Among these studies, only in the study of carbamazepine, the effect of borneol on the 
metabolite of carbamazepine was studied. Borneol also increased the distribution of the 
metabolite of carbamazepine in brain, and decreased its distribuion in lung, liver and heart, 
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also showed a brain targeting effect. However, since most of these studies only pay attention 
to the blood-brain barrier, effect of borneol on drug distribution in other tissues was 
neglected, and this limited our knowedge of borneol on the absorption, distribution, 
elimination and excretion of the studied drugs.  
2.3.2 Brain action enhancing effect of borneol  
Besides pharmacokinetics study, pharmacological method was also used to demonstrate the 
effect of borneol. Ischemic reperfusion usually induces brain injury. Although some drugs 
are effective for ischemic reperfusion, low drug concentration in brain limited their effect. 
Sodium ferulate is one of these drugs.  
Chen Xiao-Hong et al studied the brain curative enhancing effect of borneol on sodium 
ferulate by ischaemia reperfused model (X. H. Chen et al, 2010). Mice were randomly 
divided into 6 groups (n = 6): sham-treated, which was administered 10% ethanol, treated 
group included sodium ferulate 100 mg/kg per day, sodium ferulate 400 mg/kg per day, 
borneol 10 mg/kg per day, sodium ferulate 100 mg/kg +10 mg/kg borneol per day, sodium 
ferulate 400 mg/kg +10 mg/kg borneol per day. Therapy was initiated 30 min before or 
after ischaemia reperfused. To evaluate the treatment effects, tissues of the mice were 
collected for brain oedema analysis after 24 h of ischaemia reperfusion, for BBB permeability 
detection after 48 h and for Morris water maze test after 4 days of ischaemia reperfusion. 
Ischemic reperfusion model was made by the bilateral common carotid artery occlusion 
method. The results showed that compared with sham-operated group, the ischaemia 
reperfused mice were associated with long-lasting spatial learning deficits in the absence of 
other behavioral impairments and with neurodegeneration in the hippocampal CA1 region. 
However, the histological injuries were significantly attenuated by oral co-administration of 
sodium ferulate with borneol. Furthermore, combined treatment with sodium ferulate and 
borneol resulted in a significant reduction in brain oedema, gliofibrillar acid protein-positive 
cells, and blood–brain barrier permeability, but an increase in superoxide dismutase 
activity, indicating a brain targeting enhancing effect.  
Artherosclerosis is the patho-basis for coronary disease and stroke. Dioscin, a component 
from plants of dioscoreaceae, lilium and pulse family, is usually used to treat coronary 
disease but due to blood- brain barrier, it is seldomly used to treat stroke. Wang Guang-Jian 
et al investigated the cure effect of dioscin on stroke when co- administered with borneol ( 
G.J. Wang, 2010).  
Rats were divided into five groups randomly, that is control group (sham operation group), 
model group, dioscin group (0.2g / kg), dioscin (0.2g / kg) co-administered with borneol 
(0.01g/kg) and dioscin (0.2g / kg) co-administered with borneol (0.02g/kg). Animals were 
administered drugs or equal volume of isotonic Na chloride (for control and model group). 
After 7 days, besides control group, animals in other groups were made into cerebral 
ischemia model by block arteria cerebri media. After the animals were recovered, their 
neurology was given a mark. Thereafter, animals were sacrificed, brain were taken out, 
dyeing and calculated the ratio of cerebral infarction.  
The results showed that no neurologic impairment was found in control group. Animals in 
model group appeared ptosis, enophothamos, the neurology mark increased significantly, 
and cerebral infarction ratio was 12.9%. Compared with model group, cerebral infraction 
ratio and neurology mark of animals in dioscin and dioscin co-administration with low dose 
of borneol group had a tendency of decreasing, however, dioscin co-administered with high 
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dose of borneol decreased the cerebral infarction ratio and neurology mark significantly, 
indicating a very obvious synergy effect.  
2.3.3 Mechanism study of borneol 
The most accepted thought is that low drug concentration in brain is due to blood- brain 
barrier. And mechanism studies about borneol were focused on the blood- brain barrier and 
its tight junction. Zhao Bao-Sheng  and Liu Qi-De  studied the effect of borneol on blood-
brain barrier, and compared its effect with the blood-brain opening under pathological 
condition (B.S.Zhao & Q.D. Liu, 2002). The activity of anti-induce nitric oxide synthetase 
antibody (iNOS) in capillary endotheliocyte of brain was determined by streptomycin- 
bioepiderm – oxidase linking method. Compared with normal control group, iNOS in 
normal animals administered with borneol did not increase, while in animals with brain 
injured iNOS increased significantly, indicating that the opening of blood-brain barrier 
induced by borneol was different from that under pathological conditions. Ultrastructure of 
the blood-brain barrier influenced by borneol were also studied (Ge et al, 2008). It was 
showed that compared with the control group, borneol loosened the tight junction and some 
of the tight junction was not continuous. After 24h, the ultrastructure turned to normal, also 
indicating a reversible effect.  
Since many factors are not easily controlled in vivo, people studied the effect of borneol on 
tight junction of BBB using different cell models. Chen Yan-Ming & Wang Ning-Sheng et al 
studied effect of borneol on the BBB model constructed by MDCK cell line (Y.M. Chen and 
N.S. Wang, 2004). First, borneol was administrated to rabbits for 4 consective days, and blood 
were taken out, the concentration of borneol in serum determined by GC-MS was 133 µg/ mL. 
Study was carried out by comparing the BBB among MDCK cells co-cultured with serum at 
different time and concentration, containing or not containing borneol. After 4 h co-culture 
with serum containing 0.086 µmol/L borneol, the tight junction was open, after 24h co-culture 
with serum containing borneol at the same concentration, the number and volume of 
pinocytosis vesicles in the BBB cells increased significantly, thus accelerating the transport of 
substances by cell pinocytosis. However, 24h after removing serum contained borneol, effect 
of borneol disappeared and there was no difference in morphology when compared with 
normal cell. This is in accordance with the in vivo effect, also indicating a reversible effect. 
P-glycoprotein is multidrug resistant protein. There are lots of P-glycoprotein in BBB, and 
some people think it is one of the reasons that BBB restrains other drugs from getting into 
the brain. Chen Yan-Ming & Wang Ning-Sheng studied the effect of borneol on the 
vinblastine toxicity in MDCK and Hela cell line, verapamil was the positive control. It was 
found that borneol increased the toxicity of vinblatine in both cell lines significantly, and the 
increased degree was similar to that of verapamil, indicating that borneol may be able to 
inhibit the activity of P-glycoprotein (Y.M Chen. & N.S.Wang, 2003).  
Histamine and 5- hydroxytryptamine take part in the regulation of BBB, therefore, Li Wei- 
Rong et al studied the effect of borneol on the content of histamine and 5-
hydroxytryptamine. The results showed that borneol increased the contents of histamine 
and 5-hydroxytryptamine in brain significantly, indicating that effect of borneol on BBB may 
be related with histamine and 5-hydroxytryptamine (W.R. Li et al, 2006).  
2.4 Meridian guide effect of achyranthisradix 
Achyranthisradix is the radix of Achyranthes bidentata BI. It tastes sweet, a little bitter and 
sour, belongs to kidney, liver meridian. It had the effect of enforcing the function of liver 
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and kidney, strengthening bones and muscle, inducing float fire to descend and promoting 
diuresis for stranguria. In clinic, it is usually used to treat gonarthritis, swelling of throat 
caused by flaring up of stomach fire, and gingivitis etc. A famous physician Wang Ang in 
Qing dynasty said in his book <Essentials of Metea Medica> that “achyranthisradix induces 
fire to descend”. Zhang Xi-Chun said in his book <Yi Xue Zhong Zhong Can Xi Lu> that 
“achyranthisradix induces fire and blood to descend”. In book <Han Wen Tiao Bian>, it is 
described that “achyranthisradix, when used without baking, its property descends quickly, 
it could cure emia and amenia, induce other drugs to descend”. In book <Ben Cao Feng 
Yuan>, it was reported that “achyranthisradix induces other drugs to the lower part, 
arthrolithiasis of bones and muscles at the lower part should use it”. It is the meridian guide 
of lower limb. 
Pharmacological study revealed that achyranthisradix enhanced lympholeukocyte to 
reproduce, and increased the secretion of IL-2, decreased the Sil-2 content in old rats. It also 
increased the SOD activity, LPO content in old and feeble rats. Besides, it had the effect of 
anti-tumor, anti- inflammatory, anti- bacteria, and analgesic (Meng & Li, 2001). Its meridian 
guide effect was studied by pharmacokinetics combined with pharmacological method.  
Rats were divided into five groups randomly, that is normal control group, model control 
group, achyranthisradix group (5g/kg), diclofenac sodium (10mg/kg) group, 
achyranthisradix (5g/kg) co-administered with diclofenac sodium group (10mg/kg for 
diclofenac sodium). Besides normal group, Freud’s compete adjuvant (0.1mL) were injected 
at right voix pedis of rats in other groups, and made the inflammatory model for 28 days by 
measuring weights and the volume of voix pedis each week. At the 22 day, drugs were 
administered to rats and the drug administration continued to the 28 day. On the last day, 
after measuring weight and volume of voix pedis, rats were anesthetized, and blood was 
collected from hepatic portal vein. Afterwards rats were sacrificed, right voix pedis was cut 
down and the skin was removed, the soft tissues were weighed and homogenized, the 
content of diclofenac sodium in blood, and voix pedis was determined by high performance 
liquid chromatography, the content of PGE2 was determined by kit., the content of IL-1β 
was determined by radio-immunity kit.  
Compared with normal control group, right voix pedis in model group swelled significantly 
(P<0.01), both PGE and IL-1β increased significantly. In the study of diclofenac sodium, 
compared to the model group, both diclofenac sodium and its co-administration with 
achyranthisradix inhibited the swell significantly, achyranthisradix alone had marginal 
effect on the swell. Compared with diclofenac sodium, effect of inhibited swell was more 
effective in the group co-administered with achyranthisradix, showing a synergistic effect. 
Diclofenac sodium decreased both the PGE content in blood and inflammatory tissues 
significantly, and there was no difference between the decreased ratio in blood and 
inflammatory tissues. Achyranthisradix had marginal effect on PGE content, however when 
co-administered with diclofenac sodium, it decreased PGE content both in blood and 
inflammatory tissues significantly, and the decreased ratio in inflammtory tissues was more 
obvious, and this is different from the effect of diclofenac sodium. Same results was 
obtained when comparing the content of IL-1β. Both diclofenac sodium alone and co-
administration with achyranthisradix decreased the content of IL-1β significantly, the latter 
had no significance when compared with normal control group, all these results showed 
that achyranthisradix could enhance the effect of diclofenac sodium. Besides, compared 
with model group, diclofenac sodium decreased the weight of rats significantly, when co-
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administered with achyranthisradix, the weight of rats increased, indicating that 
achyranthisradix decreased the side effect of diclofenac sodium (Y.Q Lin, 2009). 
Drug concentration in tissues gave a clue for the pharmacological results. When co-
administered with achyranthisradix, concentration of diclofenac sodium in blood decreased, 
and drug concentration in inflammatory site increased significantly, the decreased and 
increased extent were 75% and 10% respectively. 
3. Meridian guide drug and transporters 
Above results showed that meridian guide drug enhanced the curative effect of the co-
administered drugs and this effect was induced by the increased distribution of other drugs in 
target site or decreased distribution in non-target site. This is in accordance with modern 
theory, and demonstrated that meridian guide drug could be used as a target delivery method. 
Drug concentration in tissues is a balance of uptake and elimination. Uptake could be 
reflected by Cmax. Almost all the results in pharmacokinetics studies showed that meridian 
guide drug increased a Cmax of other drugs in target site, this indicated that increasing the 
uptake is one of the ways for the effect of meridian guide drug. Elimination rate could be 
calculated by the concentration- time profile. Meridian guide drug usually increased the 
elimination in non- target site in above studies. Usually, drug uptake into cells and efflux to 
outside through two methods, one is passive diffusion, the other is active transport. Passive 
diffusion mainly depends on the property of the drugs, and fewer factors could affect it. 
Active transport is different, since it needs the help of carriers, factors which affected the 
activity directly or indirectly would affect its transport efficiency. Above results indicated 
that the effect of meridian guide drug may be related with influx and efflux transporters.  
Mechanism study also gives some clues for meridian guide drug with transporters. In cell 
surface, there are lots of lipid raft related with the transport of xenobiotics and endogenous 
metabolites. Vinegar-baked bupleuriradix increased the permeability of BRL cell line, and in 
high dose the cell surface changed smoothly, indicating a change at transport capability. 
Further study indicated that this change was due to membrane constituents change. 
Transporters is a kinds of protein resides in membrane and is responsible for the across of 
xenobiotics and endogenous metabolites into cells. Transporters could be divided into two 
families according to their transport directions, and they are influx transporters and efflux 
transporters. Influx transporters include organic anion transport protein (OAT), organic 
anion transport polypeptide (OATP), organic cation transport protein (OCT) and organic 
cation transport polypeptide (OCTP). Efflux transporters, also named as ATP- binding 
cassette (ABC) transporter super-family, include P- glycoprotein (P-gp), the multi-drug 
resistance protein family (MRP1-9), the breast cancer resistance protein (BCRP). There are 
many excellent reviews about them (H. Miyazaki et al, 2004; Kusuhara & Sugiyama, 2002; 
Shirata et al, 2006; M. L. Elaine et al, 2005; S. Gergely, 2008). The distribution of transporters 
is vary with different tissue, and the results are listed in Table 8. For example, OAT1 was 
expressed in kidney, brain, uterus, but OCT 1 was predominantly expressed in liver, and 
had trace amount in kidney; OAT3 was expressed in kidney, liver, brain, and eye; MRP1 
was extensively expressed in most organs, and had a high expression in lung, testicle, 
kidney, musculi skeleti, peripheral blood mononuclear cell etc, but had a relatively low 
expression in liver (B. Hagenbuch & C. Gui, 2008; M. Huls et al, 2009; M. Elaine, 2005; C. J. 
Endres, 2006). More and more studies showed that transporters play a major role in drug 
absorption, distribution, toxicity, efficacy, elimination and excretion. And it is a main reason 
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for drug-drug interaction. Some drugs affected the activity of transporters and as a 
consequence affected the distribution of the substrate of transporters (S. Eberl et al, 2007; 
A.Y. Coban et al, 2004 ; A. Seithel, et al, 2007, Sikri et al, 2004 ). Most of the meridian guide 
drugs had the effect of inhibiting the activity of P-gp (Q. Wu, 2005), and many drugs studied 
above such as resveratrol (A.Lancon et al, 2004, Juan et al, 2010), rhein (Garbap, 2002), 
levofloxacin (T. Ito et al, 1997), danshensu (P.F.Yu et al, 2011) are the substrate of P-gp or 
Mrp, indicating that meridian guide drug may influence the activity of these transporters 
and affect drug distribution and its pharmacological action. 
By analyzing the pharmacokinetics data, this hypothesis could be further elucidated. Cmax 
is a parameter reflecting drug absorption. The increase in Cmax suggested an uptake 
increase and efflux decrease in intestine. Levofloxacin is the substrate of OATP (T. Maeda et 
al, 2007), P-gp (T. Ito et al, 1997) and MRPs (H. Polache et al, 2010), which are located in 
intestine, platycodiradix inhibited the activity of P-gp and Mrps and may also increase the 
activity of OATP, the Cmax of levofloxacin increased 470%. Resveratrol is the substrate of 
MRP2 (M. E. Juan et al, 2010; Lancan A, 2004), which transported drug from the liver to 
blood and induced a significantly increased blood concentration. Drug distribution and 
elimination is the balance of drug affinity to different tissues. As shown in Table 8, different 
tissues had different transporters or different content of the same transporters, and the 
affinity with different transporters was determined by the influx and efflux rate of the drug 
and as a sequel, the balance in different tissues determined distribution, elimination, and 
excretion of the drug. 
 
Transporters Gene Transporter 
distribution 
Substrates Inhibitors 
P-gp ABCB1 brain, intestine,
liver, kidney, 
placenta, lung, 
stomach, colon, 
pancreatic gland,
oesophagus 
danshensu, 
roxithromycin, 
quinolone, 
levofloxacin, 
berberine, rifampicin, 
ofloxacin 
Bupleuri Radix, cimicifugate, 
cortex moutan, coptis 
chinensis, cortex 
phellodendri, anemarrhenae, 
Tetramethylpyrazine, 
platycodiradix, borneol, 
berberine, matrine, 
saikosaponin, paeoniflorin, 
baicalin, Roxithromycin, 
puerarin
Mrp1 ABCC1 Testicle, skeletal
muscle, heart, 
kidney, lung, 
Brain, intestine, 
liver (trace)
rhein, methotrexate puerarin 
Mrp2 ABCC2 liver, gut,
kidney, brain, 
placenta 
Methotrexate 
resveratrol 
diclofenac 
baicalein 
Tetramethylpyrazine, 
puerarin 
Mrp3 ABCC3 Adrenal gland,
Intestine, 
Pancreas, 
Gallbladder
Methotrexate Tetramethylpyrazine, 
puerarin, 
Mrp4 ABCC4 Placenta, Liver, Methotrexate  
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Transporters Gene Transporter 
distribution 
Substrates Inhibitors 
Kidney, Prostate
Ovary, Testis, 
Kidney, Lung, 
Prostate
MRP5 ABCC5 Liver, Testis, 
Skeletal and 
Cardiac Muscle, 
Brain 
 Tetramethylpyrazine 
MRP6 ABCC6 Kidney, 
keratinocytes, 
liver tracheal, 
bronchial, 
epithelium, 
intestinal 
mucosa, corneal 
epithelium, 
smooth muscle 
cell 
  
BCRP ABCG2 Placenta, colon, 
intestine, liver, 
heart, brain, 
kidney, prostate,
ovary 
Methotrexate, 
resveratrol 
Ofloxacin 
 
OAT1 SLC22A6 Kidney, brain, 
eye, placenta 
 Cidomycin, diclofenac, 
Methotrexate 
OAT2 SLC22A7 Liver, kidney  Methotrexate 
OAT3 SLC22A8 Liver, intestine, 
liver, Blood 
cerebrospinal 
fluid barrier, 
placenta 
 Methotrexate 
OAT4 SLC22A11 Liver, placenta, 
kidney, adrenals 
 Methotrexate 
OAT5 SLC22A Liver, kidney  Methotrexate 
OAT10 SLC22A13 Kidney, brain, 
heart, colon 
  
OCT1 SLC22A1 Liver, intestine, 
lung, heart, 
placenta 
  
OCT2 SLC22A2 Liver, kidney, 
brain, intestine 
  
OCT3 SLC22A3 Liver, intestine, 
placenta, 
brain,heart 
  
OCTN1 SLC22A4 Kidney, liver, 
testis, muscle, 
heart 
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Transporters Gene Transporter 
distribution 
Substrates Inhibitors 
OCTN2 SlC22A5 Kidney, liver, 
brain, intestine, 
testis 
  
OATP1A2 SLCO1A2 Brain, liver, 
kidney, eye 
Levofloxacin 
Methotraexate 
rifampicin 
OATP2B1 SLCO2B1 Brain, liver, 
kidney, placenta,
intestine 
levofloxacin Roxithromycin, rifampicin 
OATP1B1-3 SLCO1B Liver Rifampicin, 
methotrexate 
Rifampicin  
cimicifugae 
OATP3A1 SLCO ubiquitous Rifampicin, 
methotraexate 
Rifampicin 
OATP4A1 SLC ubiquitous  Rifampicin 
OATP1C1 SLC Brain, testis, 
heart, lung, eye 
 Rifampicin 
OATP1AB3 SLC Liver  Rifampicin 
PEPT1 SLC Liver, kidney, 
intestine 
  
PEPT2 SLC Kidney, brain, 
lung, spleen, 
lacteal gland 
  
Table 8. Distribution, substrate, and inhibitors of transporters. 
The activity and expression of transporters could be affected by many factors, such as 
xenobiotics, diseases, stress, metabolism enzyme, microenvironment change. And as a 
sequence, meridian guide drug may affect drug distribution by affecting these factors 
directly or indirectly. Efflux transporters are usually ATP dependent, drugs affecting ATP 
enzyme would affect activity of transporters and then affect drug effectiveness and toxicity 
(MunićV. et al, 2010; Regev et al, 1999). Bupleuriradix inhibited the activity of Na-K ATP 
enzyme (Q.L. Zhou et al, 1996), and may indirectly affected the activity of transporters. 
Different transporters may be affected by different factors, and a factor may have different 
effect on different transporters. MRP is affected by many factors, and even in this family, 
despite of a great homology in family members, factors had different effect on different 
MRPs. Drugs may affect transporters by affecting the factor and thereafter affected other 
drugs distribution. For example, MRP1 is a glutathione dependent transporter, but other 
transporters of MRP family are glutathione independent. Water extract of bupleuriradix 
increased the glutathione content (M.H. Yen et al, 2005), and enhanced the activity of MRP1. 
MRP1 is expressed widely in other tissues but less in liver, leading to a fast elimination rate 
in other tissues, while it had marginal effect on drug elimination in liver. This may be one of 
the reasons for its toxicity reducing effect.  
In spite of above well known transporters there are some transporters such as Mate1-2,  
RLIP76, and aquaporin, may play a role in meridian guide effect (Tanihara 2007, Ohta et al, 
2009; Singhal, 2009). For example, carbamazepine is an active drug for epilepsy, and it has 
drug-resistant phenomenon. P-gp was first considered as the reason, however, study 
showed it is not the substrate of P-gp (Maines, 2005). Further studies showed that it is also 
not the substrate of MRP (Luna-Tortós et al, 2010; F. Rivers, 2008), BCRP (L. Cerveny et al, 
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2006). Recently, Awasthi et al found that RLIP76, a multifunctional modular protein, was 
involved in its drug-resistance (S. Awasthi et al, 2005). Borneol increased the brain 
concentration of carbamazepine, probably by inhibiting the activity of RLIP76.  
Besides transporters, drug metabolism enzyme had an important effect on drug absorption, 
distribution, elimination and excretion. Most of meridian guide drug affected the activity of 
metabolism enzyme, such as pueraria, cassia bark, incised notopterygium rhizome, coptis 
chinensis, cortex phellodendri, evodiaefructus, angelica root, forsythia suspensa, 
paeoniaeradix and bupleuriradix, angelica dahurica etc. And this also may be one of reasons 
for its meridian guide effect (Yang et al, 2002; Mao et al, 2007, X.L. Bi et al, 2010). However, 
there are many herbs which could affect drug transporters and metabolism enzyme and 
they are not the meridian guide drug. For example, ginseng is drug usually used to 
invigorate vital energy, the main components of it not only affected drug metabolism but 
inhibited P-gp as well (C.H. Choi et al, 2003; S.W. Kim et al, 2003; S. Kitagwa Et al, 2007; Y.R. 
Pokharel, 2010); many herbs contained flavone, such as sophoraeflos, Chinese hawthom, 
soybean  which also could affect drug metabolism enzyme and transporters (R.X. Zhu et al, 
2011; Y.H. Liu et al, 2011) and only few of them are meridian guide drug, therefore, there 
must be other factors co-operating this effect and further study is required.  
4. Conclusion 
In summary, meridian guide drug had the effect of synery and attenuation, and this effect is 
based on drug concentration at target-site. Meridian guide effect had a close relationship 
with drug transporters and metabolism enzymes. Different components had different 
affinity to transporters or enzymes, and meridian guide effect is a combination of all 
components in meridian guide drug. Therefore, it is necessary to investigate the exact effect 
of main components of meridian guide drug on transporters and metabolism enzymes, 
establish the relationship between its dose and its effect as well as effects on different kinds 
of diseases. As we know more about the relationship among components in meridian guide 
drug, kinds of transporters and metabolism enzymes, activity in nomal and disease state, we 
could design target delivery system freely as desired. 
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